Ghent University Academic Bibliography

Advanced

Inhibition of tamoxifen's therapeutic benefit by tangeretin in mammary cancer.

Herman Depypere UGent, Marc Bracke UGent, Tom Boterberg UGent, Marcus Mareel, M NUYTINCK, K VENNEKENS and Rudolphe Serreyn (2000) EUROPEAN JOURNAL OF CANCER. 36(Suppl. 4). p.S73-S73
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
journal title
EUROPEAN JOURNAL OF CANCER
Eur. J. Cancer
volume
36
issue
Suppl. 4
pages
S73 - S73
Web of Science type
Article
Web of Science id
000165840000032
ISSN
0959-8049
language
English
UGent publication?
yes
classification
A1
id
173093
handle
http://hdl.handle.net/1854/LU-173093
date created
2004-01-14 13:40:00
date last changed
2016-12-19 15:38:41
@article{173093,
  author       = {Depypere, Herman and Bracke, Marc and Boterberg, Tom and Mareel, Marcus and NUYTINCK, M and VENNEKENS, K and Serreyn, Rudolphe},
  issn         = {0959-8049},
  journal      = {EUROPEAN JOURNAL OF CANCER},
  language     = {eng},
  number       = {Suppl. 4},
  pages        = {S73--S73},
  title        = {Inhibition of tamoxifen's therapeutic benefit by tangeretin in mammary cancer.},
  volume       = {36},
  year         = {2000},
}

Chicago
Depypere, Herman, Marc Bracke, Tom Boterberg, MARCUS MAREEL, M NUYTINCK, K VENNEKENS, and Rudolphe Serreyn. 2000. “Inhibition of Tamoxifen’s Therapeutic Benefit by Tangeretin in Mammary Cancer.” European Journal of Cancer 36 (Suppl. 4): S73–S73.
APA
Depypere, H., Bracke, M., Boterberg, T., MAREEL, M., NUYTINCK, M., VENNEKENS, K., & Serreyn, R. (2000). Inhibition of tamoxifen’s therapeutic benefit by tangeretin in mammary cancer. EUROPEAN JOURNAL OF CANCER, 36(Suppl. 4), S73–S73.
Vancouver
1.
Depypere H, Bracke M, Boterberg T, MAREEL M, NUYTINCK M, VENNEKENS K, et al. Inhibition of tamoxifen’s therapeutic benefit by tangeretin in mammary cancer. EUROPEAN JOURNAL OF CANCER. 2000;36(Suppl. 4):S73–S73.
MLA
Depypere, Herman, Marc Bracke, Tom Boterberg, et al. “Inhibition of Tamoxifen’s Therapeutic Benefit by Tangeretin in Mammary Cancer.” EUROPEAN JOURNAL OF CANCER 36.Suppl. 4 (2000): S73–S73. Print.